Irmer, Barnabas; Angenendt, Allegra; Camoin, Luc; Audebert, Stephane; Geyer, Christiane; Gerwing, Mirjam; Spiessbach, Hanna; Hebel, Mira; Baudelet, Émilie; Wlochowitz, Darius; Hansen, Uwe; Bleckmann, Annalen; Zimmermann, Pascale; Menck, Kerstin
Research article (journal) | Peer reviewedDespite extensive proof for the tumour-supporting function of cancer-derived small extracellular vesicles (sEVs), attributions of pathological effects to specific sEV subpopulations are poorly described. In this study, we aimed to characterise a distinct sEV species under the control of Syntenin, a key regulator of endosomal sEV biogenesis, regarding its proteomic cargo and pro-tumourigenic functions. Using mass spectrometry (MS), we detected 178 down- and 236 up-regulated proteins on sEVs from breast cancer cells upon Syntenin knockout (KO). Pathway enrichment analysis suggested that Syntenin depletion was particularly associated with adhesion-related processes. Accordingly, sEVs from Syntenin-deficient 4T1 and MCF-7 breast cancer cells showed a reduced expression of several focal adhesion and cell-cell junction proteins. Syntenin silencing reduced the Fibronectin-binding capacity of sEVs from both cell lines, which was mediated by sEV-associated Integrin alpha-V/beta-3 (αVβ3). Compared to sEVs from wildtype cells, Syntenin KO sEVs showed decreased tropism towards the Fibronectin-rich liver microenvironment in vivo, provided less adhesive support for 4T1 cells and thereby failed to induce cancer cell migration, which appeared to be independent of EV uptake. In summary, this study revealed that Syntenin has a large-scale effect on the proteomic cargo of sEVs and regulates their adhesive, organotropic and pro-migratory properties in breast cancer.
Angenendt, Allegra | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Bleckmann, Annalen | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Gerwing, Mirjam | Clinic of Radiology |
Geyer, Christiane | Clinic of Radiology |
Hansen, Uwe | Institute of Musculoskeletal Medicine (IMM) |
Irmer, Barnabas | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Menck, Kerstin | Medical Clinic of Internal Medicine A (Hematology, Oncology, and Oneumology) (Med A) |
Duration: 01/10/2020 - 30/09/2023 Funded by: Else Kröner-Fresenius-Foundation Type of project: Individual project |
Syntenin als zentraler Regulator des Cargos und der Funktion von extrazellulären Vesikeln Menck, Kerstin (29/10/2024) Workshop der Fokusgruppe für Membrantransport & Extrazelluläre Vesikel, online Type of talk: scientific talk | |
Syntenin kontrolliert die Vesikel-induzierte Tumormigration durch die Regulation der Expression von Adhäsionsproteinen auf kleinen extrazellulären Vesikeln Menck, Kerstin (17/09/2024) Joint Annual Meeting of ASEV and CzeSEV 2024, Wien Type of talk: scientific talk | |
Syntenin-1 reguliert den Export von tumorfördernden Adhäsionsproteinen auf kleine extrazelluläre Vesikel Menck, Kerstin (08/03/2024) IGLD-INSTAND Jahrestagung, Leipzig Type of talk: scientific talk |
Analyse von neuer Regulatoren der Biogenese und Funktion von extrazellulären Vesikeln Candidate: Irmer, Barnabas | Supervisors: Bleckmann, Annalen; Menck, Kerstin; Grashoff, Carsten; Busch, Karin | Reviewers: Bleckmann, Annalen; Grashoff, Carsten; Busch, Karin Period of time: 01/10/2020 - 11/06/2024 Doctoral examination procedure finished at: Doctoral examination procedure at University of Münster |